Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -81.44%. However, over the last six months, the performance has been stronger by -55.23%. The price of CHRO decreased -2.09% over the last 30 days. And in the last five days, it has surged by 41.65%.
52-week price history of CHRO Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Chromocell Therapeutics Corp.’s current trading price is -85.15% away from its 52-week high, while its distance from the 52-week low is 71.35%. The stock’s price range over this timeframe has been between $0.52 and $6.00. The shares of the Healthcare sector company recorded a trading volume of approximately 0.83 million for the day, which was comparatively higher than the average daily volume of 72500.0 over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The Connection Between Financial Performance and Market Capitalization
Chromocell Therapeutics Corp. (CHRO) has experienced a quarterly decline of -22.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.14M and boasts a workforce of 8 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0348, with a change in price of -0.5290. Similarly, Chromocell Therapeutics Corp. recorded 62,444 in trading volume during the last 100 days, posting a change of -37.25%.
CHRO Stock Stochastic Average
Chromocell Therapeutics Corp.’s raw stochastic average for the past 50 days is currently at 62.88%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 62.88%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 40.73% and 25.12%, respectively.
